In the News

Press Releases and Media Coverage

All NewsIn the NewsPress Releases
November 7, 2024

Pheast Presents New Preclinical Data for PHST001, an Anti-CD24 Macrophage Checkpoint Inhibitor, at SITC 2024

Read Article
May 13, 2024

Pheast Unveils First Preclinical Data for PHST001, an Anti-CD24 Macrophage Checkpoint Inhibitor

Read Article
April 26, 2022

Pheast Raises $76M in Series A Funding to Train the Immune System to Feast on Cancer

Read Article